Home
VRCA
VRCA News

Latest Verrica Pharmaceuticals Inc. (VRCA) News on July 27, 2024

Zevra Therapeutics (ZVRA) Surges 21.9%: Is This an Indication of Further Gains?

Zacks

16 days ago

Zevra Therapeutics (ZVRA) Surges 21.9%: Is This an Indication of Further Gains?

MT Newswires

25 days ago

Verrica Pharmaceuticals Settles Cantharidin-Related Lawsuit With Dormer Labs

Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.

GlobeNewswire

a month ago

Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.

High Insider Ownership Growth Stocks On US Exchange For June 2024

Simply Wall St.

a month ago

High Insider Ownership Growth Stocks On US Exchange For June 2024

Recent 12% pullback would hurt Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders

Simply Wall St.

a month ago

Recent 12% pullback would hurt Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York

GlobeNewswire

2 months ago

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York

High Insider Ownership Growth Companies On US Exchange May 2024

Simply Wall St.

2 months ago

High Insider Ownership Growth Companies On US Exchange May 2024

MT Newswires

2 months ago

Verrica Pharmaceuticals Amends Licensing Agreement With Torii Pharmaceutical for Phase 3 Trial of Ycanth

Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts

GlobeNewswire

2 months ago

Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts

MT Newswires

2 months ago

HC Wainwright Adjusts Price Target on Verrica Pharmaceuticals to $14 From $13, Maintains Buy Rating

MT Newswires

2 months ago

Needham Adjusts Price Target on Verrica Pharmaceuticals to $16 From $8, Keeps Buy Rating

GuruFocus.com

2 months ago

Verrica Pharmaceuticals Inc (VRCA) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2024 Results: A Detailed Financial Review

GuruFocus.com

2 months ago

Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2024 Results: A Detailed Financial Review

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates

Zacks

2 months ago

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates

Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results

GlobeNewswire

2 months ago

Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results

Verrica Pharmaceuticals to Present at Upcoming Investor Conferences

GlobeNewswire

3 months ago

Verrica Pharmaceuticals to Present at Upcoming Investor Conferences

Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024

GlobeNewswire

3 months ago

Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024

Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?

Zacks

3 months ago

Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?

Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?

Zacks

3 months ago

Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?

Strong week for Verrica Pharmaceuticals (NASDAQ:VRCA) shareholders doesn't alleviate pain of three-year loss

Simply Wall St.

4 months ago

Strong week for Verrica Pharmaceuticals (NASDAQ:VRCA) shareholders doesn't alleviate pain of three-year loss

Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

4 months ago

Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA

GlobeNewswire

4 months ago

Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA

When Will Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Become Profitable?

Simply Wall St.

5 months ago

When Will Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Become Profitable?

Verrica Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St.

5 months ago

Verrica Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q4 2023 Earnings Call Transcript

GuruFocus.com

5 months ago

Verrica Pharmaceuticals Inc (VRCA) Reports Fourth Quarter and Full-Year 2023 Financial Results

Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire

5 months ago

Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results

Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference

GlobeNewswire

5 months ago

Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference

Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024

GlobeNewswire

5 months ago

Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024

Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair Competition

GlobeNewswire

6 months ago

Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising and Unfair Competition

Verrica Pharmaceuticals Receives Permanent J-Code (J7354) for YCANTH™ from Centers for Medicare and Medicaid Services

GlobeNewswire

6 months ago

Verrica Pharmaceuticals Receives Permanent J-Code (J7354) for YCANTH™ from Centers for Medicare and Medicaid Services

HS2 bosses in talks to scrap first-class seats to maintain passenger capacity

The Telegraph

6 months ago

HS2 bosses in talks to scrap first-class seats to maintain passenger capacity

Bridgewater Bancshares, Inc. (NASDAQ:BWB) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Simply Wall St.

6 months ago

Bridgewater Bancshares, Inc. (NASDAQ:BWB) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

EPIX: Updated Data for Phase 1 Trial of Masofaniten Shows 63% of Patients Achieved PSA <0.2 ng/mL…

Zacks Small Cap Research

6 months ago

EPIX: Updated Data for Phase 1 Trial of Masofaniten Shows 63% of Patients Achieved PSA <0.2 ng/mL…

LexinFintech Holdings Ltd.'s (NASDAQ:LX) most bullish insider is CEO Wenjie Xiao, and their holdings value went up by 14% last week

Simply Wall St.

6 months ago

LexinFintech Holdings Ltd.'s (NASDAQ:LX) most bullish insider is CEO Wenjie Xiao, and their holdings value went up by 14% last week

Obsidian Energy Announces 2024 Guidance With 12 Percent Growth in Average Annual Production to 36,000 boe/d

Newsfile

6 months ago

Obsidian Energy Announces 2024 Guidance With 12 Percent Growth in Average Annual Production to 36,000 boe/d

Associated Press Finance

6 months ago

Northfield: Q4 Earnings Snapshot

Northfield Bancorp, Inc. Announces the Appointment of Dr. Rachana A. Kulkarni to Its Board of Directors

GlobeNewswire

6 months ago

Northfield Bancorp, Inc. Announces the Appointment of Dr. Rachana A. Kulkarni to Its Board of Directors

TotalEnergies (TTE) Eyes March Restart for Denmark's Tyra Field

Zacks

6 months ago

TotalEnergies (TTE) Eyes March Restart for Denmark's Tyra Field

7 Potential Short-Squeeze Stocks Poised for Rapid Gains

InvestorPlace

6 months ago

7 Potential Short-Squeeze Stocks Poised for Rapid Gains

3 Promising Blockchain Stocks to Buy to Become a Crypto Millionaire

InvestorPlace

6 months ago

3 Promising Blockchain Stocks to Buy to Become a Crypto Millionaire

GrafTech Announces Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast

Business Wire

6 months ago

GrafTech Announces Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast

Business Wire

6 months ago

Western Asset High Income Fund II Inc. Authorizes Rights Offering

Natural Grocers by Vitamin Cottage (NYSE:NGVC) Has Some Way To Go To Become A Multi-Bagger

Simply Wall St.

6 months ago

Natural Grocers by Vitamin Cottage (NYSE:NGVC) Has Some Way To Go To Become A Multi-Bagger

Business Wire

6 months ago

Putnam Investments Announces 19(a) Notices for Closed-End Municipal Funds

Tejon Ranch Company to Start Construction on Its First Residential Multi-Family Community, Terra Vista at Tejon

GlobeNewswire

7 months ago

Tejon Ranch Company to Start Construction on Its First Residential Multi-Family Community, Terra Vista at Tejon

i-80 Provides 2023 Summary & 2024 Plans - Highlighting Numerous Achievements & Catalysts

PR Newswire

7 months ago

i-80 Provides 2023 Summary & 2024 Plans - Highlighting Numerous Achievements & Catalysts

New Mountain Finance Corporation Schedules its Fourth Quarter and Year Ended December 31, 2023 Earnings Release and Conference Call

Business Wire

7 months ago

New Mountain Finance Corporation Schedules its Fourth Quarter and Year Ended December 31, 2023 Earnings Release and Conference Call

Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma

GlobeNewswire

7 months ago

Verrica Pharmaceuticals Announces Last Patient Dosed in Part 2 of Phase 2 Study of VP-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma

REX (REX) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

7 months ago

REX (REX) is on the Move, Here's Why the Trend Could be Sustainable

Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical Development of YCANTH™ for the Treatment of Common Warts

GlobeNewswire

7 months ago

Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical Development of YCANTH™ for the Treatment of Common Warts

Verrica Pharmaceuticals Announces Specialty Pharmacy Partnership Agreement with Walgreens to Distribute YCANTH™

GlobeNewswire

7 months ago

Verrica Pharmaceuticals Announces Specialty Pharmacy Partnership Agreement with Walgreens to Distribute YCANTH™

Despite recent sales, Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders remain the largest stockholders with 39% ownership

Simply Wall St.

7 months ago

Despite recent sales, Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders remain the largest stockholders with 39% ownership

AudioCodes Ltd.'s (NASDAQ:AUDC) Stock Is Going Strong: Have Financials A Role To Play?

Simply Wall St.

7 months ago

AudioCodes Ltd.'s (NASDAQ:AUDC) Stock Is Going Strong: Have Financials A Role To Play?

Investor Optimism Abounds Compass Minerals International, Inc. (NYSE:CMP) But Growth Is Lacking

Simply Wall St.

7 months ago

Investor Optimism Abounds Compass Minerals International, Inc. (NYSE:CMP) But Growth Is Lacking

Verrica Pharmaceuticals’ Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan

GlobeNewswire

7 months ago

Verrica Pharmaceuticals’ Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan

i-80 Gold Releases High-Grade Results from Underground Drilling at Granite Creek

PR Newswire

7 months ago

i-80 Gold Releases High-Grade Results from Underground Drilling at Granite Creek

Is 8.8% Yielding Redwood Trust a No-Brainer Buy or a Stock to Avoid?

Motley Fool

8 months ago

Is 8.8% Yielding Redwood Trust a No-Brainer Buy or a Stock to Avoid?

Altus Power Kicks Off December Investor Engagement

Business Wire

8 months ago

Altus Power Kicks Off December Investor Engagement

Business Wire

8 months ago

Legg Mason Partners Fund Advisor, LLC Announces Distributions for the Months of December 2023, January and February 2024

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q3 2023 Earnings Call Transcript

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

9 months ago

Q3 2023 BlackRock Capital Investment Corp Earnings Call

Savara Reports Third Quarter Financial Results and Provides Business Update

Business Wire

9 months ago

Savara Reports Third Quarter Financial Results and Provides Business Update

GuruFocus.com

9 months ago

BlackRock Capital Investment Corp (BKCC) Reports Solid Earnings Growth and NAV Increase for Q3 2023

Associated Press Finance

9 months ago

BlackRock Kelso: Q3 Earnings Snapshot

BlackRock Capital Investment Corporation Reports Financial Results for the Quarter Ended September 30, 2023, Declares Quarterly Cash Dividend of $0.10 per Share

Business Wire

9 months ago

BlackRock Capital Investment Corporation Reports Financial Results for the Quarter Ended September 30, 2023, Declares Quarterly Cash Dividend of $0.10 per Share

Business Wire

9 months ago

JBG SMITH Announces Third Quarter 2023 Results

ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights

GlobeNewswire

9 months ago

ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights

Thomson Reuters StreetEvents

9 months ago

Q1 2024 1-800-Flowers.Com Inc Earnings Call

1-800-Flowers.com Inc (FLWS) Reports Q1 2024 Earnings: Net Loss of $31.2 Million

GuruFocus.com

9 months ago

1-800-Flowers.com Inc (FLWS) Reports Q1 2024 Earnings: Net Loss of $31.2 Million

John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) Q1 2024 Earnings Call Transcript

Insider Monkey

9 months ago

John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) Q1 2024 Earnings Call Transcript

Share on Social Networks: